Přejít k hlavnímu obsahu
Header image

Jorda Radek

Journals

DELGADO, T., V. D., H. DOSTÁLOVÁ, V. KRYŠTOF, V. VOJÁČKOVÁ, R. JORDA, A. CASTRO, J. BERTRAND, G. RIVERA, M. FAUNDEZ, M. STRNAD, C. ESPINOSA-BUSTOS, O. SALAS C.
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics. 2024, 16(5), 649, ISSN: 1999-4923, PMID: 38794311,  PDF.
KOVALOVA, M., J. BARAKA, V. MIK, R. JORDA, M. LUO, H. SHAO, V. KRYŠTOF
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022). Expert Opinion on Therapeutic Patents. 2023, 33(2), 67-87, ISSN: 1354-3776, PMID: 36975020,  PDF.
KOVALOVA, M., L. HAVLICEK, S. DJUKIC, J. SKERLOVA, M. PERINA, T. POSPÍŠIL, E. ŘEZNÍČKOVÁ, P. ŘEZÁČOVÁ, R. JORDA, V. KRYŠTOF
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7. Biomedicine & Pharmacotherapy. 2023, 161, 114492, ISSN: 0753-3322, PMID: 36931035,  PDF.